SCHEMBL16857580

SCHEMBL16857580

COc1cccc(-c2cc(O)n(-c3ccccn3)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 0.51
DYRK1A Q13627 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
ALDH1A1 P00352 2/20 0.46
HPGD P15428 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GRM5 P41594 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TOP1 P11387 1/20 0.44
PKM P14618 1/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
DCTPP1 Q9H773 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12003370 0.87 NPY5R (0.55) CLK4ALDH1A1HPGDNPC1RAB9A
SCHEMBL12003356 0.86 NPY5R (0.54) CLK4ALDH1A1HPGDNPC1RAB9A
SCHEMBL16864370 0.83 ALDH1A1 (0.49) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL12003341 0.83 ALDH1A1 (0.48) ALDH1A1HPGDNPC1RAB9AGRM5
SCHEMBL12003404 0.83 ALDH1A1 (0.48) ALDH1A1HPGDNPC1RAB9AGRM5
SCHEMBL12003459 0.82 PDCD1 (0.49) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL12018161 0.82 ALDH1A1 (0.55) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL15609960 0.81 ALDH1A1 (0.54) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL27755767 0.81 SLC16A3 (0.48) SLC16A3DYRK1ACLK4ALDH1A1HPGD
SCHEMBL12003474 0.81 GRM5 (0.44) ALDH1A1SMN1; SMN2GRM5LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2889032-B1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE UNIV EWHA IND COLLABORATION (KR) 2019-05-08 EP disclosed
EP-2889032-B1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE UNIV EWHA IND COLLABORATION (KR) 2019-05-08 EP disclosed
US-20150218125-A1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) 2015-08-06 US disclosed
US-20150218125-A1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) 2015-08-06 US disclosed
EP-2889032-A1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE Ewha University-Industry Collaboration Foundation (KR) 2015-07-01 EP disclosed
EP-2889032-A1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE Ewha University-Industry Collaboration Foundation (KR) 2015-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218125-A1 COMPOSITION FOR PREVENTING OR TREATING KIDNEY DISEASE COMPRISING PYRAZOLE DERIVATIVE REN, GLS, ATP6V1B1 SLC16A3 1838/4885DYRK1A 3483/4885CLK4 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.